Neurology

Patients at Wake Forest Baptist Medical Center know they will have access to tomorrow’s technology, today. Wake Forest’s membership in a consortium of 10 leading U.S. medical centers, called the New Approaches to Brain Tumor Therapy, allows access to promising new clinical trials. 

The Neurology department offers a variety of new and innovative research and clinical trials that focus on areas such as Parkinson's disease, Epilepsy, Stroke, Spasticity, Multiple Sclerosis, ALS, and Huntington's disease

We are also conducting research with High-resolution, relational, resonance-based, electroencephalic mirroring (HIRREM®). This is a novel, noninvasive, electroencephalic-based feedback technology to facilitate relaxation and auto-calibration of neural oscillations by using auditory tones to reflect brain frequencies in near real time. 

 

Find A Doctor Ways to Give

Spotlight

Blazeman Foundation Provides $200,000 to Produce Critical Protein Used in Lou Gehrig’s Disease Research

Blazeman Foundation Provides $200,000 to Produce Critical Protein Used in Lou Gehrig’s Disease Research

The ALS Research Group at Wake Forest Baptist Medical Center, led by researcher Carol Milligan, Ph.D., neurobiology and anatomy, is looking for ways to treat Amyotrophic Lateral Sclerosis (ALS), more commonly known as Lou Gehrig's disease. Her recent work, using “heat shock” proteins to help control muscle movement, showed that their use in mice delayed the onset of ALS symptoms and extended survival times.

Last Updated: 10-07-2014
USNWR 2013-2014Magnet Hospital RecognitionConsumer Choice2014 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.